SCHEMBL9397884

SCHEMBL9397884

OC1CCCCCSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL523741 0.97
SCHEMBL1929406 0.89
Hydrochloric Acid SCHEMBL31706459 0.86
Alcohol SCHEMBL11031868 0.78 TSHR (0.33)
SCHEMBL676835 0.77 TSHR (0.32)
SCHEMBL3924268 0.77
SCHEMBL3271432 0.77 TSHR (0.32)
SCHEMBL756745 0.77
SCHEMBL2202738 0.77
SCHEMBL69923 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1573543-B Photosensitive metal nanoparticle and method of forming conductive pattern using the same SAMSUNG ELECTRONICS CO LTD 2010-05-12 CN disclosed
CN-1573543-A Photosensitive metal nanoparticle and method of forming conductive pattern using the same SAMSUNG ELECTRONICS CO LTD (KR) 2005-02-02 CN disclosed
EP-0593461-A1 3-SUBSTITUTED-1-(ARYL OR ARYLALKYL)-2(1H)-QUINOLINONES SCHERING CORPORATION (US) 1994-04-27 EP disclosed
EP-0495917-A1 LIPOXYGENASE INHIBITORS SCHERING CORPORATION (US) 1992-07-29 EP disclosed
WO-1991007401-A1 3-SUBSTITUTED-1-(ARYL OR ARYLALKYL)-2(1H)-QUINOLINONES SCHERING CORPORATION (US) 1991-05-30 WO disclosed
WO-1991005757-A1 LIPOXYGENASE INHIBITORS SCHERING CORPORATION (US) 1991-05-02 WO disclosed